Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

DaVita HealthCare Partners Inc Add to portfolio

INX:DVA, Aug 17, 03:48 UTC

Latest INX:DVA News

Filter your feed

Apply Filter

Thursday, August 09


Social Chatter

Thursday, August 02


News

DaVita (DVA) Beats Earnings and Revenue Estimates in Q2 - August 2, 2018

DVA

Total revenues declined 25.5% year over year to $2.89 billion, but beat the Zacks Consensus Estimate of $2.88 billion. Adjusted Kidney Care operating income was $438 million, up 12% year over year. As an operating division of the company, DaVita Kidney Care focuses on setting worldwide standards for clinical, social and operational practices in kidney care. During the second quarter, DaVita repurchased a total of 7.8 million shares for approximately $512 million, at an average price of $65.60 per share. Intuitive Surgical reported adjusted earnings of $2.76 per share in the second quarter of 2018, which beat the Zacks Consensus Estimate of $2.48.

Read Full Details

Topics:
  • Business
  • Financial
News

DaVita’s Q2 2018 Earnings Surpass Analysts’ Estimates

DVA

DaVita (DVA) released its second-quarter earnings after the market closed on August 1. It surpassed Wall Street analysts’ estimates for revenues and EPS and reported non-GAAP EPS of $1.15 on revenues of $2.9 billion. The EPS estimate was $0.97 on revenues of $2.8 billion.

Read Full Details

Topics:
  • Business
  • Financial

Wednesday, August 01


News

DaVita HealthCare (DVA) Tops Q2 Earnings and Revenue Estimates - August 1, 2018

DVA

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for DaVita HealthCare was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future.

Read Full Details

Topics:
  • Business
  • Financial
News

DaVita HealthCare: 2Q Earnings Snapshot

DVA

DENVER (AP) _ DaVita HealthCare Partners Inc. (DVA) on Wednesday reported second-quarter profit of $267.3 million. On a per-share basis, the Denver-based company said it had profit of $1.53. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 97 cents per share. DaVita HealthCare shares have decreased nearly 3 percent since the beginning of the year, while the Standard & Poor's 500 index has increased 5 percent.

Read Full Details

Topics:
  • Business
  • Financial
Social Chatter

Tuesday, July 31


News

EPS for DaVita Inc. (DVA) Expected At $0.97

DVA

Oppenheimer And, New York-based fund reported 17,837 shares. Northstar Gru Inc Inc holds 0.38% or 11,034 shares. National Insur Tx holds 0.32% in DaVita Inc. (NYSE:DVA) or 94,850 shares. Pub Employees Retirement System Of Ohio holds 0.03% of its portfolio in DaVita Inc. (NYSE:DVA) for 74,860 shares. Analysts expect DaVita Inc. (NYSE:DVA) to report $0.97 EPS on August, 1 after the close.They anticipate $0.05 EPS change or 5.43 % from last quarter’s $0.92 EPS.

Read Full Details

Topics:
  • Business
  • Health
  • Financial
News

Analysts’ Recommendations for DaVita

DVA

As discussed previously, analysts expect DaVita (DVA) to post revenue of $2.877 billion, adjusted net income of ~$175.97 million, and non-GAAP EPS of ~$0.97 in Q2 2018. Of the ten analysts tracking DaVita, five recommend “strong buy,” four recommend “hold,” and one recommends “sell.”.

Read Full Details

Topics:
  • Business
  • Financial
News

What to Expect for DaVita’s Q2 2018 Earnings

DVA

DaVita (DVA), which divides its business into two segments, DaVita Kidney Care and DaVita Medical Group, is set to release its Q2 2018 results tomorrow. Analysts expect it to post EPS of $0.97 on revenue of $2.8 billion. The chart below shows DaVita’s EPS and revenue since Q1 2017, as well as analysts’ Q2 2018 estimates.

Read Full Details

Topics:
  • Business
  • Financial

Tuesday, July 24


News

DaVita Inc. (DVA) EPS Estimated At $0.97

DVA

It improved, as 35 investors sold DaVita Inc. shares while 159 reduced holdings. 145.68 million shares or 0.35% more from 145.16 million shares in 2017Q4 were reported. Fmr Ltd Liability Corporation has 0.02% invested in DaVita Inc. (NYSE:DVA) for 2.56 million shares. New York-based Orbimed Ltd has invested 1.28% in DaVita Inc. (NYSE:DVA). Since May 14, 2018, it had 0 insider buys, and 3 insider sales for $211,988 activity.

Read Full Details

Topics:
  • Business
  • Health
  • Financial